Most-used long-read sequencers ranked by how many preprints say they used each
Long-read sequencers read single DNA or RNA molecules thousands of bases long, often far longer. That's enough to span the repeats and rearrangements that short reads miss. Updated daily (as of Nov 16)
Nanopore PromethION is the most-used long-read sequencer.
Nanopore PromethION had 40% of the uses in Jun–Nov 2026, up from 39% the year before. Nanopore MinION is second with 33%.
| # | Platform | Last 6 months | Growth | Share | Total | By year |
|---|---|---|---|---|---|---|
| 1 | 285 preprints | +18% | 40%up from 39% | 887 39% | ||
| 2 | 241 preprints | −5% | 33%down from 41% | 844 37% | ||
| 3 | 195 preprints | +53% | 27%up from 21% | 535 24% |
Last 6 months is Jun–Nov 2026. Growth compares it with Jun–Nov 2025, as a share of all preprints. Total counts every preprint since April 2025 that says it used the platform.
Top institutions for each platform
Stanford University16
University of Washington14
Australian National University9
University of Copenhagen9
Norwegian University of Life Sciences9
University of Washington12
University of Pittsburgh10
Imperial College London7
Uppsala University7
Academia Sinica6
Counts every preprint since April 2025, by the corresponding author's institution.
PacBio Revio is growing fastest.
Up 53% in Jun–Nov 2026 vs the previous year as a share of all preprints. Nanopore PromethION was up 18% and Nanopore MinION down 5%. All three together grew 16%. Compare side by side: Revio vs PromethION →
PromethION
MinION
Revio
The last bar is the quarter so far.
Latest preprints using long-read sequencing
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.